M.B. PHARMOS A/S: Financial statements 2014
CVR: 18776405
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
M.B. PHARMOS A/S (CVR 18776405) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 25,630 and a net result of DKK 30,563 compared with DKK -229,668 the year before. Equity in the 2014 report amounted to DKK 1,818,452. The solvency ratio was 99.4%.
- Gross Profit
- DKK 25,630
- Profit/Loss
- DKK 30,563
- Equity
- DKK 1,818,452
- Total Assets
- DKK 1,828,833
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 26 t. | 31 t. | 1.8 mio. | - |
| 2013 | - | -310 t. | -230 t. | 1.8 mio. | - |
| 2012 | - | -803 t. | 24 t. | 2.1 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
M.B. PHARMOS A/S has published its annual report for 2013. Gross profit came to DKK -310,430, and the net result was DKK -229,668.
As of April 8, 2014, Susanne Lauritsen has joined the board of directors of M.B. PHARMOS A/S.
As of April 8, 2014, Laurits Henning Lauritsen has joined the board of directors of M.B. PHARMOS A/S.
As of April 8, 2014, Pernille Ulrich Berthelsen has joined the board of directors of M.B. PHARMOS A/S.
As of April 8, 2014, Jesper Breuning-Hansen has left the board of directors of M.B. PHARMOS A/S.
As of April 8, 2014, Laurits Henning Lauritsen is registered as adm. dir. of M.B. PHARMOS A/S.
About M.B. PHARMOS A/S
M.B. PHARMOS A/S was a Danish company of the type Aktieselskab based in København Ø, founded in 1995. The company has been dissolved on 6 December 2019. The company was registered under the industry Specialiseret engroshandel med fødevarer i.a.n.. The company was previously named M.B. PHARMOS ApS and ApS KBUS 8 NR. 4186. The company has 0 employees (2017). In 2018, the company reported a gross profit of DKK -790 and a net result of DKK 44,121 compared with DKK 32,984 the year before. Equity in the 2018 report amounted to DKK 1,954,455.